Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Death, Sudden, Cardiac | 76 | 2021 | 1568 | 7.330 |
Why?
|
Defibrillators, Implantable | 75 | 2024 | 1497 | 6.390 |
Why?
|
Tachycardia, Ventricular | 52 | 2024 | 1313 | 4.740 |
Why?
|
Tachycardia | 68 | 2014 | 598 | 2.440 |
Why?
|
Electrophysiologic Techniques, Cardiac | 23 | 2024 | 511 | 1.990 |
Why?
|
Anti-Arrhythmia Agents | 42 | 2020 | 772 | 1.880 |
Why?
|
Primary Prevention | 18 | 2020 | 1187 | 1.770 |
Why?
|
Heart Conduction System | 30 | 2021 | 1007 | 1.740 |
Why?
|
Ventricular Dysfunction, Left | 21 | 2020 | 2136 | 1.690 |
Why?
|
Cardiac Pacing, Artificial | 63 | 2019 | 882 | 1.680 |
Why?
|
Arrhythmias, Cardiac | 46 | 2020 | 2255 | 1.640 |
Why?
|
Electrocardiography | 90 | 2024 | 6409 | 1.570 |
Why?
|
Catheter Ablation | 27 | 2024 | 2787 | 1.560 |
Why?
|
Ventricular Fibrillation | 19 | 2018 | 538 | 1.550 |
Why?
|
Stroke Volume | 38 | 2024 | 5595 | 1.540 |
Why?
|
Electric Countershock | 27 | 2019 | 536 | 1.530 |
Why?
|
Myocardial Infarction | 40 | 2019 | 11508 | 1.000 |
Why?
|
Coronary Disease | 36 | 2013 | 5919 | 0.880 |
Why?
|
Tachycardia, Supraventricular | 8 | 2018 | 272 | 0.860 |
Why?
|
Heart Ventricles | 40 | 2024 | 3833 | 0.860 |
Why?
|
Atrial Flutter | 8 | 2015 | 253 | 0.770 |
Why?
|
Heart Atria | 11 | 2018 | 1363 | 0.730 |
Why?
|
Risk Assessment | 34 | 2020 | 24275 | 0.710 |
Why?
|
Cardiac Electrophysiology | 2 | 2018 | 60 | 0.710 |
Why?
|
Heart Rate | 16 | 2021 | 4203 | 0.700 |
Why?
|
Electrophysiology | 49 | 2023 | 1264 | 0.690 |
Why?
|
Heart Failure | 29 | 2019 | 11837 | 0.680 |
Why?
|
Atrial Fibrillation | 21 | 2019 | 5186 | 0.640 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1735 | 0.630 |
Why?
|
Ventricular Function, Left | 11 | 2024 | 3930 | 0.580 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 5 | 2021 | 148 | 0.570 |
Why?
|
Cicatrix | 5 | 2024 | 796 | 0.510 |
Why?
|
Ventricular Premature Complexes | 5 | 2019 | 112 | 0.500 |
Why?
|
Peptide Fragments | 2 | 2020 | 5126 | 0.480 |
Why?
|
Action Potentials | 6 | 2020 | 1837 | 0.460 |
Why?
|
Endocardium | 13 | 2019 | 249 | 0.450 |
Why?
|
Electrocardiography, Ambulatory | 5 | 2010 | 582 | 0.440 |
Why?
|
Coronary Artery Disease | 11 | 2015 | 6544 | 0.440 |
Why?
|
Procainamide | 12 | 1993 | 56 | 0.430 |
Why?
|
Pulmonary Veins | 5 | 2018 | 757 | 0.430 |
Why?
|
Heart Arrest | 24 | 2015 | 1516 | 0.430 |
Why?
|
Practice Guidelines as Topic | 10 | 2018 | 7423 | 0.420 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2018 | 1457 | 0.420 |
Why?
|
Proportional Hazards Models | 17 | 2017 | 12529 | 0.420 |
Why?
|
Kidney Function Tests | 1 | 2015 | 684 | 0.400 |
Why?
|
Diagnostic Techniques, Cardiovascular | 3 | 2011 | 153 | 0.400 |
Why?
|
Cardiology | 9 | 2020 | 1696 | 0.380 |
Why?
|
Humans | 265 | 2024 | 765926 | 0.380 |
Why?
|
Death, Sudden | 15 | 2005 | 301 | 0.370 |
Why?
|
Randomized Controlled Trials as Topic | 21 | 2019 | 10380 | 0.360 |
Why?
|
Echocardiography | 7 | 2018 | 5040 | 0.360 |
Why?
|
Adrenergic beta-Antagonists | 8 | 2017 | 1238 | 0.350 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 594 | 0.350 |
Why?
|
Myocardial Ischemia | 3 | 2018 | 2132 | 0.340 |
Why?
|
Biometry | 1 | 2013 | 571 | 0.340 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2015 | 562 | 0.330 |
Why?
|
Heart Diseases | 11 | 2023 | 2818 | 0.320 |
Why?
|
Patient Selection | 6 | 2019 | 4248 | 0.320 |
Why?
|
Aged | 117 | 2024 | 171163 | 0.310 |
Why?
|
Treatment Outcome | 38 | 2023 | 65194 | 0.310 |
Why?
|
Middle Aged | 139 | 2024 | 223016 | 0.300 |
Why?
|
Male | 147 | 2024 | 363815 | 0.290 |
Why?
|
American Heart Association | 8 | 2023 | 1045 | 0.290 |
Why?
|
Therapeutic Irrigation | 2 | 2019 | 297 | 0.290 |
Why?
|
Risk Factors | 43 | 2023 | 74850 | 0.290 |
Why?
|
Amiodarone | 13 | 2008 | 216 | 0.280 |
Why?
|
Glomerular Filtration Rate | 2 | 2015 | 2233 | 0.270 |
Why?
|
Device Removal | 3 | 2018 | 643 | 0.270 |
Why?
|
Heart | 17 | 2021 | 4419 | 0.270 |
Why?
|
Torsades de Pointes | 2 | 2020 | 78 | 0.270 |
Why?
|
Female | 144 | 2024 | 396141 | 0.260 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2011 | 855 | 0.260 |
Why?
|
Prognosis | 27 | 2020 | 29890 | 0.250 |
Why?
|
Electrodiagnosis | 3 | 2016 | 149 | 0.250 |
Why?
|
Prosthesis Failure | 5 | 2019 | 1194 | 0.240 |
Why?
|
Bundle-Branch Block | 12 | 2015 | 280 | 0.240 |
Why?
|
Multicenter Studies as Topic | 6 | 2017 | 1729 | 0.240 |
Why?
|
Swine | 9 | 2019 | 5986 | 0.230 |
Why?
|
Societies, Medical | 7 | 2020 | 3953 | 0.230 |
Why?
|
Models, Statistical | 2 | 2016 | 5088 | 0.230 |
Why?
|
Equipment Failure | 5 | 2020 | 580 | 0.230 |
Why?
|
Follow-Up Studies | 35 | 2024 | 39228 | 0.220 |
Why?
|
Survival Rate | 14 | 2018 | 12822 | 0.220 |
Why?
|
Atrioventricular Node | 10 | 2021 | 180 | 0.220 |
Why?
|
Cardiomyopathies | 10 | 2018 | 2068 | 0.220 |
Why?
|
Time Factors | 40 | 2020 | 40097 | 0.220 |
Why?
|
Sleep Apnea, Obstructive | 3 | 2017 | 1898 | 0.210 |
Why?
|
Autonomic Nervous System | 3 | 2016 | 706 | 0.210 |
Why?
|
Predictive Value of Tests | 12 | 2018 | 15401 | 0.200 |
Why?
|
Cardiomyopathy, Hypertrophic | 5 | 2015 | 1338 | 0.200 |
Why?
|
Cause of Death | 5 | 2019 | 3715 | 0.190 |
Why?
|
Prospective Studies | 27 | 2020 | 54807 | 0.190 |
Why?
|
Biomedical Research | 1 | 2017 | 3458 | 0.190 |
Why?
|
Mitral Valve Prolapse | 2 | 2000 | 213 | 0.190 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3690 | 0.180 |
Why?
|
Isoproterenol | 4 | 1997 | 398 | 0.180 |
Why?
|
Data Collection | 2 | 2006 | 3318 | 0.180 |
Why?
|
Coronary Artery Bypass | 5 | 2002 | 2188 | 0.170 |
Why?
|
United States | 32 | 2023 | 72909 | 0.170 |
Why?
|
Cardiomyopathy, Dilated | 6 | 2000 | 844 | 0.170 |
Why?
|
Survivors | 1 | 2010 | 2373 | 0.170 |
Why?
|
Electric Injuries | 1 | 2019 | 24 | 0.170 |
Why?
|
Recurrence | 16 | 2024 | 8492 | 0.160 |
Why?
|
Body Surface Potential Mapping | 3 | 2019 | 228 | 0.160 |
Why?
|
Decision Support Techniques | 3 | 2019 | 2004 | 0.160 |
Why?
|
Medicare | 2 | 2018 | 6815 | 0.160 |
Why?
|
Retrospective Studies | 25 | 2024 | 81537 | 0.160 |
Why?
|
Defibrillators | 1 | 2018 | 39 | 0.150 |
Why?
|
Belgium | 1 | 2018 | 119 | 0.150 |
Why?
|
Verapamil | 5 | 1987 | 242 | 0.150 |
Why?
|
Ventricular Function | 3 | 1997 | 403 | 0.150 |
Why?
|
Ventricular Remodeling | 2 | 2016 | 1276 | 0.150 |
Why?
|
Bradycardia | 4 | 2009 | 304 | 0.150 |
Why?
|
Myocardial Contraction | 4 | 2018 | 1516 | 0.140 |
Why?
|
Fraud | 1 | 2018 | 66 | 0.140 |
Why?
|
Electroshock | 1 | 2017 | 120 | 0.140 |
Why?
|
Probability | 2 | 2016 | 2474 | 0.140 |
Why?
|
Advisory Committees | 2 | 2011 | 796 | 0.140 |
Why?
|
Atherosclerosis | 3 | 2018 | 3419 | 0.130 |
Why?
|
Myocardial Revascularization | 2 | 2018 | 795 | 0.130 |
Why?
|
Catheters | 1 | 2019 | 427 | 0.130 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15645 | 0.130 |
Why?
|
Protein Precursors | 1 | 2020 | 1133 | 0.130 |
Why?
|
Aged, 80 and over | 14 | 2019 | 59496 | 0.130 |
Why?
|
Heart Function Tests | 4 | 2014 | 317 | 0.130 |
Why?
|
Cardiac Complexes, Premature | 2 | 1992 | 63 | 0.120 |
Why?
|
Insurance Coverage | 2 | 2018 | 1945 | 0.120 |
Why?
|
Tachycardia, Paroxysmal | 2 | 2014 | 30 | 0.120 |
Why?
|
Thermometers | 1 | 2015 | 42 | 0.120 |
Why?
|
Heart Valve Prosthesis | 1 | 2023 | 1464 | 0.120 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2019 | 325 | 0.120 |
Why?
|
Sympathetic Nervous System | 2 | 2015 | 521 | 0.120 |
Why?
|
Clinical Trials as Topic | 8 | 2017 | 8037 | 0.110 |
Why?
|
Ablation Techniques | 1 | 2017 | 254 | 0.110 |
Why?
|
Survival Analysis | 8 | 2014 | 10086 | 0.110 |
Why?
|
Syncope | 6 | 2014 | 431 | 0.110 |
Why?
|
Comorbidity | 9 | 2018 | 10575 | 0.110 |
Why?
|
Risk | 16 | 2014 | 9599 | 0.110 |
Why?
|
Therapeutic Equipoise | 1 | 2013 | 29 | 0.110 |
Why?
|
Myocardium | 3 | 2019 | 4764 | 0.110 |
Why?
|
Consensus | 2 | 2020 | 3202 | 0.110 |
Why?
|
Chi-Square Distribution | 4 | 2016 | 3430 | 0.110 |
Why?
|
Sinoatrial Node | 6 | 2007 | 99 | 0.100 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2017 | 341 | 0.100 |
Why?
|
North America | 1 | 2016 | 1287 | 0.100 |
Why?
|
Affect | 2 | 2021 | 1494 | 0.100 |
Why?
|
Equipment Design | 4 | 2019 | 3490 | 0.100 |
Why?
|
Stellate Ganglion | 1 | 2012 | 52 | 0.100 |
Why?
|
Computer Simulation | 3 | 2016 | 6251 | 0.100 |
Why?
|
Baroreflex | 2 | 2011 | 153 | 0.100 |
Why?
|
Heart Failure, Systolic | 1 | 2014 | 135 | 0.100 |
Why?
|
Sympathectomy | 1 | 2012 | 72 | 0.100 |
Why?
|
Diffusion of Innovation | 1 | 2017 | 723 | 0.100 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2014 | 127 | 0.100 |
Why?
|
Research Support as Topic | 1 | 1996 | 697 | 0.100 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2015 | 698 | 0.100 |
Why?
|
Electrocoagulation | 2 | 1989 | 157 | 0.090 |
Why?
|
Vectorcardiography | 2 | 2024 | 48 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 7 | 2017 | 6503 | 0.090 |
Why?
|
Health Services | 1 | 1996 | 756 | 0.090 |
Why?
|
Atrial Septum | 1 | 2011 | 61 | 0.090 |
Why?
|
Alloys | 1 | 2011 | 109 | 0.090 |
Why?
|
Bayes Theorem | 2 | 2016 | 2353 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2023 | 2022 | 0.090 |
Why?
|
History, 21st Century | 1 | 2017 | 1572 | 0.090 |
Why?
|
Vocabulary | 1 | 2011 | 166 | 0.090 |
Why?
|
Atrial Appendage | 1 | 2014 | 284 | 0.090 |
Why?
|
Health Behavior | 1 | 2022 | 2649 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2015 | 811 | 0.090 |
Why?
|
Stroke | 2 | 2023 | 9739 | 0.090 |
Why?
|
Punctures | 1 | 2011 | 372 | 0.080 |
Why?
|
Evaluation Studies as Topic | 2 | 2011 | 1607 | 0.080 |
Why?
|
Electric Stimulation | 11 | 2004 | 1738 | 0.080 |
Why?
|
Cost of Illness | 1 | 2019 | 1949 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2530 | 0.080 |
Why?
|
History, 20th Century | 1 | 2017 | 2760 | 0.080 |
Why?
|
Incidence | 9 | 2020 | 21513 | 0.080 |
Why?
|
Esophagus | 1 | 2015 | 1038 | 0.080 |
Why?
|
Algorithms | 5 | 2018 | 14064 | 0.080 |
Why?
|
Latin America | 2 | 2020 | 416 | 0.080 |
Why?
|
Terminology as Topic | 4 | 2011 | 1536 | 0.080 |
Why?
|
Propranolol | 4 | 1984 | 494 | 0.080 |
Why?
|
Decision Making | 2 | 2013 | 3955 | 0.080 |
Why?
|
Asia | 2 | 2020 | 630 | 0.080 |
Why?
|
Monitoring, Intraoperative | 1 | 2015 | 944 | 0.080 |
Why?
|
Organotechnetium Compounds | 1 | 2008 | 134 | 0.080 |
Why?
|
Chest Pain | 1 | 2015 | 1102 | 0.080 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2013 | 581 | 0.070 |
Why?
|
3-Iodobenzylguanidine | 1 | 2008 | 114 | 0.070 |
Why?
|
Patient-Centered Care | 2 | 2019 | 1447 | 0.070 |
Why?
|
Body Height | 1 | 2013 | 1561 | 0.070 |
Why?
|
Organophosphorus Compounds | 1 | 2008 | 209 | 0.070 |
Why?
|
Adult | 64 | 2017 | 223088 | 0.070 |
Why?
|
Refractory Period, Electrophysiological | 4 | 1997 | 40 | 0.070 |
Why?
|
Prevalence | 3 | 2016 | 15828 | 0.070 |
Why?
|
Minnesota | 2 | 2018 | 339 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2007 | 14643 | 0.070 |
Why?
|
Confidence Intervals | 2 | 2014 | 2915 | 0.070 |
Why?
|
Injections, Intravenous | 8 | 2010 | 1376 | 0.060 |
Why?
|
Bundle of His | 3 | 2021 | 102 | 0.060 |
Why?
|
Positron-Emission Tomography | 2 | 2015 | 6542 | 0.060 |
Why?
|
Europe | 3 | 2020 | 3430 | 0.060 |
Why?
|
Registries | 5 | 2016 | 8346 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 4 | 2011 | 1513 | 0.060 |
Why?
|
Ventricular Dysfunction | 1 | 2006 | 143 | 0.060 |
Why?
|
Nitroglycerin | 3 | 1982 | 331 | 0.060 |
Why?
|
Sus scrofa | 2 | 2018 | 430 | 0.060 |
Why?
|
Hypotension | 3 | 1987 | 885 | 0.060 |
Why?
|
Animals | 13 | 2019 | 168735 | 0.060 |
Why?
|
Monitoring, Physiologic | 8 | 1988 | 1793 | 0.060 |
Why?
|
Unconsciousness | 1 | 1987 | 250 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5936 | 0.060 |
Why?
|
Quinidine | 4 | 1991 | 52 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 1 | 2011 | 1195 | 0.060 |
Why?
|
Heart Transplantation | 2 | 1996 | 3310 | 0.060 |
Why?
|
Polysomnography | 2 | 2013 | 1868 | 0.060 |
Why?
|
Long QT Syndrome | 1 | 2009 | 474 | 0.060 |
Why?
|
Iodine Radioisotopes | 1 | 2008 | 1029 | 0.060 |
Why?
|
Ergonovine | 2 | 1982 | 14 | 0.060 |
Why?
|
Electric Impedance | 2 | 2019 | 792 | 0.060 |
Why?
|
Acute Disease | 3 | 2012 | 7236 | 0.060 |
Why?
|
Oximetry | 1 | 2007 | 458 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2023 | 5300 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20133 | 0.050 |
Why?
|
Quality Assurance, Health Care | 2 | 2011 | 2170 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4959 | 0.050 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 1143 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18292 | 0.050 |
Why?
|
Family Practice | 1 | 1985 | 508 | 0.050 |
Why?
|
Microcirculation | 1 | 2007 | 1282 | 0.050 |
Why?
|
Coronary Vasospasm | 1 | 1982 | 81 | 0.050 |
Why?
|
Pilot Projects | 2 | 2023 | 8724 | 0.050 |
Why?
|
Postoperative Complications | 6 | 2014 | 15802 | 0.050 |
Why?
|
Dogs | 1 | 2007 | 3824 | 0.050 |
Why?
|
Forecasting | 4 | 2014 | 2936 | 0.050 |
Why?
|
Pacemaker, Artificial | 5 | 2010 | 829 | 0.050 |
Why?
|
Angina Pectoris, Variant | 1 | 1981 | 52 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 1985 | 441 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2234 | 0.050 |
Why?
|
Drug Evaluation | 4 | 1993 | 642 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3615 | 0.040 |
Why?
|
Fluoroquinolones | 1 | 2003 | 307 | 0.040 |
Why?
|
Canada | 2 | 2002 | 2120 | 0.040 |
Why?
|
Diagnosis, Differential | 5 | 2015 | 12973 | 0.040 |
Why?
|
Clinical Competence | 3 | 2001 | 4855 | 0.040 |
Why?
|
Infusions, Parenteral | 2 | 1984 | 395 | 0.040 |
Why?
|
Spasm | 1 | 1980 | 131 | 0.040 |
Why?
|
Databases, Factual | 2 | 2018 | 8060 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5889 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2014 | 2307 | 0.040 |
Why?
|
Boston | 3 | 2018 | 9334 | 0.040 |
Why?
|
Quality of Health Care | 2 | 2011 | 4305 | 0.040 |
Why?
|
Angina Pectoris | 2 | 1994 | 957 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15878 | 0.040 |
Why?
|
Steam | 1 | 2018 | 34 | 0.040 |
Why?
|
Disposable Equipment | 1 | 1978 | 45 | 0.040 |
Why?
|
Mitral Valve Stenosis | 1 | 2001 | 342 | 0.040 |
Why?
|
United States Government Agencies | 1 | 2018 | 26 | 0.040 |
Why?
|
Prosthesis Design | 3 | 2013 | 2111 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12803 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2701 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12059 | 0.040 |
Why?
|
Republic of Korea | 1 | 2020 | 583 | 0.040 |
Why?
|
Drug Contamination | 1 | 1979 | 151 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6838 | 0.040 |
Why?
|
Retreatment | 1 | 2019 | 598 | 0.040 |
Why?
|
Acinetobacter Infections | 1 | 1978 | 74 | 0.040 |
Why?
|
Exercise Test | 4 | 2006 | 2185 | 0.040 |
Why?
|
Dextrocardia | 1 | 1976 | 37 | 0.030 |
Why?
|
Regression Analysis | 3 | 2014 | 6321 | 0.030 |
Why?
|
Peritoneal Dialysis | 1 | 1978 | 161 | 0.030 |
Why?
|
Recovery of Function | 2 | 2018 | 2963 | 0.030 |
Why?
|
Infusions, Intra-Arterial | 2 | 1991 | 219 | 0.030 |
Why?
|
Education | 1 | 2019 | 531 | 0.030 |
Why?
|
Enterobacteriaceae Infections | 1 | 1978 | 190 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2014 | 36547 | 0.030 |
Why?
|
Patient Readmission | 3 | 2015 | 3282 | 0.030 |
Why?
|
Coronary Vessels | 4 | 1988 | 3094 | 0.030 |
Why?
|
Flecainide | 1 | 1996 | 41 | 0.030 |
Why?
|
Logistic Models | 3 | 2015 | 13273 | 0.030 |
Why?
|
Heart Septum | 1 | 1976 | 303 | 0.030 |
Why?
|
Tricuspid Valve | 1 | 1999 | 421 | 0.030 |
Why?
|
Linear Models | 2 | 2016 | 5873 | 0.030 |
Why?
|
Heart Valve Diseases | 2 | 1999 | 1029 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2003 | 985 | 0.030 |
Why?
|
Sex Characteristics | 2 | 1999 | 2645 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1752 | 0.030 |
Why?
|
New York | 1 | 2017 | 880 | 0.030 |
Why?
|
Economic Competition | 1 | 1996 | 223 | 0.030 |
Why?
|
Disease Progression | 3 | 2018 | 13614 | 0.030 |
Why?
|
Necrosis | 1 | 2018 | 1611 | 0.030 |
Why?
|
Indiana | 1 | 2014 | 93 | 0.030 |
Why?
|
Research Design | 2 | 2016 | 6204 | 0.030 |
Why?
|
Hospitalization | 4 | 2013 | 10810 | 0.030 |
Why?
|
Cardiomegaly | 1 | 1976 | 590 | 0.030 |
Why?
|
Cardiac Output, Low | 2 | 2006 | 192 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2011 | 4863 | 0.030 |
Why?
|
Systole | 1 | 2016 | 935 | 0.030 |
Why?
|
Aortic Valve | 1 | 2023 | 1964 | 0.030 |
Why?
|
Benzofurans | 2 | 1985 | 139 | 0.030 |
Why?
|
Temperature | 1 | 2019 | 2226 | 0.030 |
Why?
|
Munchausen Syndrome | 1 | 1972 | 19 | 0.030 |
Why?
|
Heart Block | 3 | 1984 | 391 | 0.030 |
Why?
|
Pulmonary Edema | 1 | 2015 | 409 | 0.030 |
Why?
|
Syndrome | 1 | 1999 | 3271 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2015 | 358 | 0.020 |
Why?
|
Cross Infection | 2 | 1979 | 1426 | 0.020 |
Why?
|
Diuretics | 1 | 2015 | 611 | 0.020 |
Why?
|
Decision Trees | 1 | 2014 | 509 | 0.020 |
Why?
|
Models, Animal | 1 | 2018 | 2120 | 0.020 |
Why?
|
Single-Blind Method | 2 | 2007 | 1587 | 0.020 |
Why?
|
Health Services Research | 1 | 2019 | 1811 | 0.020 |
Why?
|
Chronic Disease | 2 | 2002 | 9351 | 0.020 |
Why?
|
Psychotherapy | 1 | 2021 | 1648 | 0.020 |
Why?
|
Age Factors | 4 | 2015 | 18382 | 0.020 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2014 | 269 | 0.020 |
Why?
|
Life Expectancy | 1 | 2018 | 1247 | 0.020 |
Why?
|
Electric Power Supplies | 1 | 2012 | 94 | 0.020 |
Why?
|
Foundations | 1 | 2011 | 95 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1673 | 0.020 |
Why?
|
Cohort Studies | 4 | 2015 | 41680 | 0.020 |
Why?
|
Troponin | 1 | 2014 | 532 | 0.020 |
Why?
|
Quality of Life | 3 | 2019 | 13463 | 0.020 |
Why?
|
Radiography | 2 | 2015 | 6941 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2010 | 151 | 0.020 |
Why?
|
Jervell-Lange Nielsen Syndrome | 1 | 2009 | 4 | 0.020 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2009 | 72 | 0.020 |
Why?
|
Epicardial Mapping | 1 | 2009 | 58 | 0.020 |
Why?
|
Disease Outbreaks | 2 | 1978 | 1761 | 0.020 |
Why?
|
Differential Threshold | 1 | 1989 | 80 | 0.020 |
Why?
|
Postoperative Period | 1 | 2014 | 1818 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1186 | 0.020 |
Why?
|
Neural Conduction | 1 | 2010 | 442 | 0.020 |
Why?
|
Digitalis Glycosides | 1 | 2008 | 47 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2630 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2010 | 358 | 0.020 |
Why?
|
Procaine | 1 | 1988 | 60 | 0.020 |
Why?
|
Sex Factors | 3 | 2007 | 10611 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2014 | 1093 | 0.020 |
Why?
|
Combined Modality Therapy | 3 | 2009 | 8522 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2015 | 1093 | 0.020 |
Why?
|
Sepsis | 2 | 1979 | 2603 | 0.020 |
Why?
|
Genetic Testing | 2 | 2014 | 3594 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1993 | 1435 | 0.020 |
Why?
|
Laboratories | 1 | 2011 | 463 | 0.020 |
Why?
|
Electrophysiological Phenomena | 1 | 2009 | 308 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 1994 | 1721 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2011 | 945 | 0.020 |
Why?
|
Lidocaine | 2 | 1988 | 545 | 0.020 |
Why?
|
Patient Satisfaction | 2 | 2012 | 3477 | 0.020 |
Why?
|
Adolescent | 16 | 1996 | 88811 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26282 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16714 | 0.020 |
Why?
|
Disopyramide | 2 | 1983 | 16 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1997 | 10727 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 971 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2014 | 996 | 0.020 |
Why?
|
Propanolamines | 2 | 1983 | 163 | 0.020 |
Why?
|
Goals | 1 | 2011 | 717 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2227 | 0.020 |
Why?
|
Heart Aneurysm | 2 | 1982 | 114 | 0.020 |
Why?
|
Propensity Score | 1 | 2013 | 1971 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4085 | 0.020 |
Why?
|
London | 1 | 1985 | 233 | 0.020 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2011 | 1060 | 0.010 |
Why?
|
Cardiovascular System | 1 | 2012 | 838 | 0.010 |
Why?
|
Propiophenones | 1 | 1984 | 28 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2011 | 1394 | 0.010 |
Why?
|
Coronary Angiography | 4 | 1996 | 4498 | 0.010 |
Why?
|
Education, Medical | 1 | 1996 | 1744 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2009 | 1563 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2010 | 1238 | 0.010 |
Why?
|
Atrial Function | 1 | 1984 | 98 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 831 | 0.010 |
Why?
|
Insurance, Health | 1 | 1996 | 2520 | 0.010 |
Why?
|
Metoprolol | 1 | 1984 | 90 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2009 | 979 | 0.010 |
Why?
|
Timolol | 1 | 1983 | 51 | 0.010 |
Why?
|
Mexiletine | 1 | 1983 | 30 | 0.010 |
Why?
|
Policy Making | 1 | 2007 | 546 | 0.010 |
Why?
|
Electroencephalography | 2 | 2009 | 6274 | 0.010 |
Why?
|
Population Surveillance | 1 | 2013 | 2596 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9656 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4729 | 0.010 |
Why?
|
Administration, Oral | 3 | 1996 | 4016 | 0.010 |
Why?
|
Cardiovascular Agents | 1 | 2009 | 848 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22228 | 0.010 |
Why?
|
Propylamines | 1 | 1983 | 161 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2006 | 1985 | 0.010 |
Why?
|
Nifedipine | 1 | 1982 | 220 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14745 | 0.010 |
Why?
|
Reoperation | 1 | 2012 | 4308 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8882 | 0.010 |
Why?
|
Physical Exertion | 1 | 1983 | 666 | 0.010 |
Why?
|
Health Care Costs | 1 | 2014 | 3241 | 0.010 |
Why?
|
Proteomics | 1 | 2014 | 3906 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6491 | 0.010 |
Why?
|
Phlebitis | 1 | 1979 | 34 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 1986 | 1273 | 0.010 |
Why?
|
Enterobacter | 1 | 1978 | 44 | 0.010 |
Why?
|
Staphylococcus | 1 | 1979 | 145 | 0.010 |
Why?
|
Coronary Care Units | 1 | 1980 | 235 | 0.010 |
Why?
|
Pseudomonas | 1 | 1979 | 124 | 0.010 |
Why?
|
Shock | 1 | 1981 | 316 | 0.010 |
Why?
|
Research | 1 | 2007 | 1974 | 0.010 |
Why?
|
Acinetobacter | 1 | 1978 | 39 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5925 | 0.010 |
Why?
|
Disease Reservoirs | 1 | 1978 | 123 | 0.010 |
Why?
|
Transducers | 1 | 1978 | 238 | 0.010 |
Why?
|
Cineangiography | 1 | 1976 | 108 | 0.010 |
Why?
|
Education, Medical, Continuing | 1 | 2001 | 829 | 0.010 |
Why?
|
Diarrhea, Infantile | 1 | 1976 | 100 | 0.010 |
Why?
|
Candida albicans | 1 | 1979 | 377 | 0.010 |
Why?
|
Angiography | 1 | 1981 | 1589 | 0.010 |
Why?
|
Peritonitis | 1 | 1978 | 368 | 0.010 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 1996 | 65 | 0.010 |
Why?
|
Enterotoxins | 1 | 1976 | 366 | 0.010 |
Why?
|
Diatrizoate | 1 | 1994 | 81 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2007 | 5531 | 0.010 |
Why?
|
Ischemia | 1 | 1982 | 1901 | 0.010 |
Why?
|
Hypertension | 1 | 2013 | 8616 | 0.010 |
Why?
|
Catheterization | 1 | 1978 | 1426 | 0.010 |
Why?
|
Ultrasonography | 1 | 2006 | 5987 | 0.010 |
Why?
|
Escherichia coli Infections | 1 | 1976 | 519 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2006 | 3530 | 0.010 |
Why?
|
Treatment Failure | 1 | 1997 | 2653 | 0.010 |
Why?
|
Pennsylvania | 1 | 1972 | 615 | 0.010 |
Why?
|
Pyridines | 1 | 1983 | 2885 | 0.010 |
Why?
|
Resuscitation | 2 | 1985 | 681 | 0.010 |
Why?
|
Internal Medicine | 1 | 1997 | 1064 | 0.010 |
Why?
|
Curriculum | 1 | 2001 | 3784 | 0.000 |
Why?
|
Observer Variation | 1 | 1994 | 2611 | 0.000 |
Why?
|
Electrodes | 1 | 1988 | 609 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1994 | 6202 | 0.000 |
Why?
|
Acecainide | 1 | 1984 | 1 | 0.000 |
Why?
|
Propafenone | 1 | 1984 | 27 | 0.000 |
Why?
|
Drug Therapy, Combination | 2 | 1986 | 6306 | 0.000 |
Why?
|
Escherichia coli | 1 | 1976 | 4210 | 0.000 |
Why?
|
Nadolol | 1 | 1983 | 29 | 0.000 |
Why?
|
Purkinje Fibers | 1 | 1983 | 31 | 0.000 |
Why?
|
Ambulatory Care | 2 | 1985 | 2778 | 0.000 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 1984 | 117 | 0.000 |
Why?
|
Cardiac Surgical Procedures | 1 | 1978 | 3682 | 0.000 |
Why?
|
Blood Pressure | 1 | 1978 | 8530 | 0.000 |
Why?
|
Photosensitivity Disorders | 1 | 1982 | 79 | 0.000 |
Why?
|
Phenytoin | 1 | 1983 | 189 | 0.000 |
Why?
|
Drug Combinations | 1 | 1988 | 2075 | 0.000 |
Why?
|
Postoperative Care | 1 | 1986 | 1475 | 0.000 |
Why?
|
Pulmonary Fibrosis | 1 | 1982 | 503 | 0.000 |
Why?
|
Data Interpretation, Statistical | 1 | 1988 | 2688 | 0.000 |
Why?
|
Drug Resistance | 1 | 1983 | 1588 | 0.000 |
Why?
|
Chloramphenicol | 1 | 1976 | 67 | 0.000 |
Why?
|
Corneal Diseases | 1 | 1982 | 535 | 0.000 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1982 | 710 | 0.000 |
Why?
|
Colistin | 1 | 1976 | 46 | 0.000 |
Why?
|
Drug Resistance, Microbial | 1 | 1976 | 832 | 0.000 |
Why?
|
Hot Temperature | 1 | 1976 | 1433 | 0.000 |
Why?
|
Software | 1 | 1983 | 4462 | 0.000 |
Why?
|
Mice | 1 | 1985 | 81782 | 0.000 |
Why?
|
Infant | 1 | 1976 | 36426 | 0.000 |
Why?
|
Child | 1 | 1982 | 80568 | 0.000 |
Why?
|